false000031361600003136162021-01-132021-01-130000313616us-gaap:CommonStockMember2021-01-132021-01-130000313616us-gaap:PreferredStockMember2021-01-132021-01-130000313616us-gaap:SeriesBPreferredStockMember2021-01-132021-01-130000313616dhr:FloatingRateSeniorNotesDue2022Member2021-01-132021-01-130000313616dhr:A17SeniorNotesDue2024Member2021-01-132021-01-130000313616dhr:A2.5SeniorNotesDue2025Member2021-01-132021-01-130000313616dhr:A0.2SeniorNotesDue2026Member2021-01-132021-01-130000313616dhr:A21SeniorNotesDue2026Member2021-01-132021-01-130000313616dhr:A1.2SeniorNotesDue2027Member2021-01-132021-01-130000313616dhr:A0.45SeniorNotesDue2028Member2021-01-132021-01-130000313616dhr:A25SeniorNotesDue2030Member2021-01-132021-01-130000313616dhr:A0.75SeniorNotesDue2031Member2021-01-132021-01-130000313616dhr:A1.35SeniorNotesDue2039Member2021-01-132021-01-130000313616dhr:A1.8SeniorNotesDue2049Member2021-01-132021-01-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 13, 2021
__________________
DHR-20210113_G1.JPG
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
__________________
Delaware 001-08089 59-1995548
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
2200 Pennsylvania Avenue, NW 20037-1701
Suite 800W
Washington, DC
(Address of Principal Executive Offices)   (Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, $0.01 par value DHR New York Stock Exchange
4.75% Mandatory Convertible Preferred Stock, Series A, without par value DHR.PRA New York Stock Exchange
5.00% Mandatory Convertible Preferred Stock, Series B, without par value DHR.PRB New York Stock Exchange
Floating Rate Senior Notes due 2022 DHR/22A New York Stock Exchange
1.700% Senior Notes due 2024 DHR 24 New York Stock Exchange
2.500% Senior Notes due 2025 DHR/25 New York Stock Exchange
0.200% Senior Notes due 2026 DHR/26 New York Stock Exchange
2.100% Senior Notes due 2026 DHR 26 New York Stock Exchange
1.200% Senior Notes due 2027 DHR/27 New York Stock Exchange
0.450% Senior Notes due 2028 DHR/28 New York Stock Exchange
2.500% Senior Notes due 2030 DHR 30 New York Stock Exchange
0.750% Senior Notes due 2031 DHR/31 New York Stock Exchange
1.350% Senior Notes due 2039 DHR/39 New York Stock Exchange
1.800% Senior Notes due 2049 DHR/49 New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 


ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On January 13, 2021, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference on the same date, Danaher Corporation issued a press release regarding the Company’s anticipated financial performance for the fourth quarter of 2020 and furnished pursuant to Item 2.02 of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher’s anticipated financial performance for 2020.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits:
Exhibit No.    Description
99.1   
99.1PRE
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date: January 13, 2021 By: /s/ Matthew R. McGrew
Matthew R. McGrew
Executive Vice President and Chief Financial Officer


Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Danaher Charts.
Danaher (NYSE:DHR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Danaher Charts.